Image: for section 'More than a million reasons to join us.'

More than a million reasons to join us.

I am proud to a part of a movement to bring women’s health issues to the forefront of medical research. It is the opportunity of a lifetime to change the future for Generations of men, women, and children.


Image: for section 'The need has never been greater.'

The need has never been greater.

The need has never been greater for a more focused, more dedicated approach to women’s health, specifically in the areas of maternity and early human development, gender-specific medicine, and infectious diseases. Over the years, a lack of funding in these areas has slowed the progress of important research and clinical trials that could yield new cures, more powerful treatments, and innovative therapies. It also has affected our ability to recruit the best minds in medicine who are on the cusp of breakthrough discoveries that will not only help women, children, and infants – but also give us insights and knowledge into issues that affect men’s health. It’s time to refocus our energies and intelligence on women’s health, and Magee-Womens Research Institute is leading the way.

Three Pillars of Research

This is a movement to transform the way the medical world studies and treats women. No other Institute in the nation is more uniquely qualified to impact the world of women’s health in dramatic and lasting ways than Magee-Womens Research Institute.

9-90 Research

Our breakthrough 9-90 research studies the 9 months of pregnancy to identify ways to prevent and cure illnesses and diseases that can occur over the next 90 years of a person’s life.

Gender-Specific Medicine

Our research in gender-specific medicine is yielding powerful insights into women’s cancers, pelvic floor health, fertility, metabolism, drugs and medications, aging, and medical disorders that affect women and men in a distinctive manner, all from the unique platform of a woman’s biology.

Infectious Diseases

Finally, we are focusing our efforts on the global threat of infectious diseases and our clinical trials are yielding breakthrough results all over the world.